Market: NMS |
Currency: USD
Address: 2118 Walsh Avenue
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
📈 HeartBeam, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$5.83
-
Upside/Downside from Analyst Target:
222.28%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
2026-03-20
-
EPS Estimate:
-0.14
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for HeartBeam, Inc.
| Date | Reported EPS |
|---|
| 2026-03-19 (estimated upcoming) | - |
| 2025-11-13 | -0.15 |
| 2025-08-13 | -0.15 |
| 2025-05-13 | -0.18 |
| 2025-03-13 | -0.18 |
| 2024-11-07 | -0.19 |
| 2024-08-14 | -0.19 |
| 2024-05-09 | -0.17 |
| 2024-03-20 | -0.13 |
| 2023-11-14 | -0.13 |
| 2023-08-10 | -0.16 |
| 2023-05-11 | -0.5 |
| 2023-03-16 | -0.45 |
| 2022-11-10 | -0.44 |
| 2022-08-11 | -0.43 |
📰 Related News & Research
No related articles found for "heartbeam inc".